Treatment With Aspirin After Preeclampsia: TAP Trial
Recruiting · NCT06281665 · Interventional (participants receive a specific treatment) · Lead sponsor: Malamo Countouris
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The objective of this research project is to conduct a single-site pilot trial to assess the feasibility and effect of low-dose aspirin to augment vascular recovery in the immediate postpartum period after preeclampsia through two specific aims: 1) to pilot test the feasibility of conducting a randomized controlled trial of postpartum low dose aspirin vs. placebo, and 2) to assess the effect of postpartum aspirin on endothelial function and blood pressure. Our central hypothesis is that postpartum administration of low-dose aspirin following preeclampsia will be feasible, improve endothelial function, and lower BP at 6 months postpartum. Subjects will undergo 3 study visits involving BP measurements, blood draws, questionnaires, and/or microiontophoresis. Up to 60 adult subjects will be enrolled at Magee-Women's Hospital.
Who can take part
Inclusion criteria
- Postpartum individuals ≥18 years old
- Preeclampsia diagnosis
Exclusion criteria
- Fetal anomaly
- Multiple gestation
- Pre-pregnancy hypertension
- Allergy or contraindication to low-dose aspirin
- Pre-pregnancy diabetes
Where it is running
1 location listed across 1 US state.
- University of Pittsburgh Magee-Womens Hospital - Pittsburgh, Pennsylvania, United States